Skip to main content

Table 2 Contingency tables and cut-offs

From: Baseline levels of dynamic CD4+ T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study

A

 

Response

Non-Response

 

Dynamic adhesion

>  8.5 cells/3 min

6

0

PPV: 100%

Dynamic adhesion

<  8.5 cells/3 min

6

9

NPV: 60%

 

Sensitivity: 50%

Specificity: 100%

 

B

 

Non-Response

Response

 

Dynamic adhesion

<  2.5 cells/3 min

5

2

PPV: 71.4%

Dynamic adhesion

>  2.5 cells/3 min

4

10

NPV: 71.4%

 

Sensitivity: 55.6%

Specificity: 83.3%

 

C

 

Response

Non-Response

 

Reduction of adhesion

>  8.5 cells/3 min

6

0

PPV: 100%

Reduction of adhesion

<  8.5 cells/3 min

6

9

NPV: 60%

 

Sensitivity: 50%

Specificity: 100%

 

D

 

Non-Response

Response

 

Reduction of adhesion

<  2.5 cells/3 min

6

2

PPV: 75%

Reduction of adhesion

>  2.5 cells/3 min

3

10

NPV: 76.9%

 

Sensitivity: 66.7%

Specificity: 83.3%

 

E

 

Response

Non-Response

 

Dynamic adhesion

>  8.5 cells/3 min

6

0

PPV: 100%

Reduction of adhesion

>  2.5 cells/3 min

Dynamic adhesion

<  8.5 cells/3 min

4

3

 

Reduction of adhesion

>  2.5 cells/3 min

Dynamic adhesion

<  8.5 cells/3 min

2

6

NPV: 75%

Reduction of adhesion

<  2.5 cells/3 min